Levofloxacin NDC 33342-531

NDC codes

FDA NDC Directory

Product NDC (as listed)33342-531Labeler and product segments. Claims need a package NDC.

Product NDC at billing width33342-0531Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
33342-531-08	33342053108	50 TABLET, FILM COATED in 1 BOTTLE (33342-531-08)Marketed from Mar 22, 2012
33342-531-11	33342053111	100 TABLET, FILM COATED in 1 BOTTLE (33342-531-11)Marketed from Mar 22, 2012
33342-531-12	33342053112	100 TABLET, FILM COATED in 1 BLISTER PACK (33342-531-12)Marketed from Mar 22, 2012
33342-531-31	33342053131	50 TABLET, FILM COATED in 1 BLISTER PACK (33342-531-31)Marketed from Mar 22, 2012

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Levofloxacin
Generic name (nonproprietary): levofloxacin
Active ingredients: Levofloxacin — 250 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Macleods Pharmaceuticals Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 200839
Marketing start: Mar 22, 2012
Listing expires: Dec 31, 2026
Identifiers: Product ID 33342-531_fc165a6d-24b0-4753-a7ac-94a134dca0d3SPL ID fc165a6d-24b0-4753-a7ac-94a134dca0d3SPL set ID fc165a6d-24b0-4753-a7ac-94a134dca0d3RxCUI 199884, 199885, 311296UNII 6GNT3Y5LMFUPC 0333342533111, 0333342531087, 0333342532084, 0333342533326, 0333342531117, 0333342532114

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N433342053108 followed by a unit qualifier and the quantity

Package 33342-0531-08. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 6, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

Levofloxacin tablets are fluoroquinolone antibacterial indicated in adults (18 years of age and older) with infections caused by designated, susceptible bacteria and in pediatric patients where indicated ( 1 , 12.4 ). • Pneumonia: Nosocomial ( 1.1 ) and Community Acquired ( 1.2 , 1.3 ) • Skin and Skin Structure Infections (SSSI): Complicated ( 1.4 ) and Uncomplicated ( 1.5 ) • Chronic bacterial prostatitis ( 1.6 ) • Inhalational Anthrax, Post-Exposure in adult and pediatric patients ( 1.7 ) • Plague in adult and pediatric patients ( 1.8 ) • Urinary Tract Infections (UTI): Complicated ( 1.9 , 1.10 ) and Uncomplicated ( 1.12 ) • Acute Pyelonephritis ( 1.11 ) • Acute Bacterial Exacerbation of C…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 200839

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 200839
Product	Strength	Form · route	Labeler	Product NDC
Levofloxacin	Levofloxacin 500 mg/1	Tablet, Film coatedOral	Macleods Pharmaceuticals Limited	33342-532
Levofloxacin	Levofloxacin 750 mg/1	Tablet, Film coatedOral	Macleods Pharmaceuticals Limited	33342-533
Levofloxacin	Levofloxacin 500 mg/1	Tablet, Film coatedOral	Redpharm Drug	67296-0743